Uncategorized

Roche scraps two Ionis-partnered Huntington’s drugs

Published

on

The Swiss pharmaceutical giant told patient groups tominersen didn’t delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal in animal testing.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version